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Abstract
Problem statement and significance: Left undiagnosed and/or untreated, the
short-and long-term sequelae of postpartum depression may negatively impact both
mother and child. In Western countries, access to mental health care is influenced
by socioeconomic factors. The objective of this systematic literature review is to
compile factors that hinder and improve access to postpartum depression treatment
in low-income women after a positive screen for postpartum depression. The key
question of focus is: what are the characteristics associated with access to mental
health treatment for low-income women with a positive postpartum depression
screen in Western countries?
Methods: A PRISMA-based systematic literature review was conducted of studies
published in English before February 2016 that looked at treatment for postpartum
depression in low-income women who had been identified with the condition.
PubMed and EBSCO databases were searched using MESH and key terms and found
100 articles that met the selection criteria. After review by two independent researchers,
18 studies with 17 unique populations were included in the literature review.
Results: Two independent abstractors searched the included articles for themes
surrounding impediments and advantages for low-income women identified with
postpartum depression in obtaining mental health treatment. Characteristics of
successful mental health treatment included studies that employed the use of a home
visitor and those that separated outcomes for women with previous mental health
treatment. Themes that emerged as treatment obstacles included cultural barriers,
physical barriers, systemic health care barriers, and social barriers.
Implications for practice: This review will help to better inform screening and
treatment priorities for those in the medical field who may encounter women
experiencing postpartum depression and are not aware of the various barriers to care
specific to low-income women. This review will also help policymakers identify specific
obstacles that are not addressed in postpartum screening mandate policies which can
affect the implementation of these policies.
Keywords: Postpartum depression, Postpartum depression screening, Postpartum
depression treatment, Mental health, Women’s health
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Background
Women are at risk to develop depression after childbirth, also known as the postpar-
tum period [1]. Postpartum depression (PPD), defined as nonpsychotic depression
occurring up to 1 year after childbirth, is a “crippling mood disorder that erodes away
at the joy and happiness of new mothers” [2–4]. PPD is recognized as an international
public health concern. There is an estimated prevalence of PPD of 10–20% among
mothers in Western countries [5–7]. The few studies that have examined PPD
prevalence in developing countries show similar or higher prevalence of this condition
[5, 6, 8, 9]. If undiagnosed and/or untreated, PPD can adversely affect the mother and
child, as well as the mother-child relationship [3]. For the mother, PPD has a dele-
terious effect on all social and familial relationships, functional status (including
impaired parenting behaviors), and ability to care for the infant and herself, includ-
ing increasing the risk of the mother harming herself. Maternal suicides account
for up to 20% of all postpartum deaths [10, 11]. The infant is at increased risk for
long-term health and developmental problems (including cognitive, language, and
school delays) and behavioral issues [1, 2, 4, 12].
Although the exact etiology of PPD has not been determined, there are known risk
factors for developing this condition [13]. Women with lower socioeconomic status or
educational attainment, history of depression prior to pregnancy, lack of social support,
history of substance use/abuse, previous birth(s), and lower employment status are at
higher risk for developing PPD [1, 2, 7, 14]. Studies have shown that PPD occurs two
to four times as often for women living in poverty, as compared to middle-or-upper-in-
come women; socioeconomic status is often thought to be the most consistent pre-
dictor of PPD [1, 2, 4, 7, 11, 12, 15]. In the USA, the population most at risk for PPD is
disproportionately represented by racial/ethnic minorities, such as African-American
and Hispanic women. Perhaps relatedly, these are the populations affected the most by
health care inequities associated with the lack of resources characteristic of low
socioeconomic status [11, 16].
The most significant factor in the duration of PPD is the time it takes for the new
mother to receive adequate, individualized treatment in the form of pharmacological,
psychotherapeutic, and/or social support intervention [3, 10, 12, 17]. Although it does
not guarantee treatment, the woman must first be screened for PPD, which is often
accomplished using a tool such as the Edinburgh Postnatal Depression Scale (EPDS) or
the Postpartum Depression Screening Scale or a self-report used as a proxy for clinical
assessment [4, 14, 16, 18]. Routine screening is encouraged, but not mandated, in most
Western countries, but it is estimated that only about half of women in these countries
with PPD receive any type of evaluation or treatment for the condition [6, 7, 11, 14].
Low-income women have lower rates of screening and treatment for PPD, in part due
to lack of knowledge about PPD, economic barriers, and stigma [14].
The objective of this systematic literature review is to summarize the practices used
to screen for PPD, as well as assess barriers to mental health treatment after a positive
screen is received, among low-income women. The key question we want to address is:
what are the characteristics associated with access to mental health treatment for low-
income women with a positive postpartum depression screen in Western countries?
This review initially looked at literature with no geographic boundaries, but only
studies from Western countries fit the inclusion criteria. For this review, PPD
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symptoms are treated as either a clinical diagnosis of postpartum depression or a self-
diagnosis of PPD by study participants. Studies included in the review will be examined to
determine how authors established the definition of a positive PPD screen and the rate
and process by which women were referred for and sought treatment. Perceived barriers
to treatment will be extracted from the articles to gain a broader understanding of the
obstacles to mental health treatment for low-income postpartum women with PPD. The
review targets low-income women, as this population universally has more barriers to care
and thus is more vulnerable than women with greater access to resources.
Global history of PPD
A brief historical overview is provided for context to help readers better understand
the nature of the problem today.
Mood disturbances and psychoses during the postpartum period have been described
since at least the time of Hippocrates, who considered the illnesses to originate specif-
ically within the puerperal and lactation periods [19, 20]. The first published paper
devoted specifically to puerperal mental illness was printed in 1858 by Louis-Victor
Marcé. Marcé’s Treatise on Insanity in Pregnant, Postpartum and Lactating Women
found that although the symptoms that pregnant and postpartum women were experi-
encing could be found in other mental disturbances, the combination of symptoms was
distinct to the functional changes occurring within the reproductive system after
childbirth and should therefore be classified as a separate diagnosis [21].
However, there was no consensus on the definition of depression in postpartum
women until the late twentieth century. In the mid-1900s, Britain differentiated post-
partum psychiatric disorders from nonpuerperal mental illness, but the USA viewed
PPD either as harmless, fleeting “baby blues,” or as affective or schizophrenic episodes
[21, 22]. Seeking a universal definition, clinicians and researchers began advocating for
a clinical diagnosis of PPD in order for the condition to be recognized by health care
systems [23]. In the USA, PPD was formally recognized in 1994 as a clinical diagnosis
in the Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM) to validate the stress some new mothers experience during the postpartum
period [13]. Outside of the DSM, in Western countries, there are currently three
accepted types of postpartum mood disorders: postpartum blues, the most common
postpartum mood syndrome, defined as a mild and short-lasting ailment; PPD, an
episode of major or minor depressive disorder in the postpartum period; and postpar-
tum psychosis, a rare, acute psychiatric episode in the postpartum period [18, 21].
Integrating mental health screening into primary care for pregnant and postpartum
women and providing follow-up and treatment is a growing concern worldwide [18].
Australia and New Zealand have published national recommendations stating that it is
the provider’s responsibility to be aware of the risks of PPD, to be able to identify the
condition and to make the appropriate referrals for mental health treatment. Similarly,
the Norwegian government is endorsing initiatives targeted at mental health issues in
women during and after pregnancy [11]. In the USA, the Patient Protection and
Affordable Care Act (ACA) went into effect in 2010 and contains language for provid-
ing support services to women and research support for PPD. Even before the ACA,
individual states such as New Jersey (2006) and Illinois (2008) took action towards
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mandating screening or physician reimbursement for screening for PPD [18]. When
examining strategies to better incorporate mental health care in developing countries,
the World Health Organization found that the use of short validated screening tools
has been effective in detecting patients with issues like PPD. In a study performed in
Nigeria, the EPDS was an effective tool in identifying women with PPD [5].
Much of the research about PPD (including screening and treatment) has been
confined to Western countries. Although the physiology of human pregnancy is the
same worldwide, the mother’s experience is greatly impacted by cultural factors. Some
cultures do not recognize PPD, and mothers are sometimes reluctant to admit symp-
toms due to cultural expectations of women’s behavior in motherhood. Since PPD is
not universally recognized and treated, more research is needed across cultures to aid
in a fuller understanding of the burden of PPD globally [20].
Methods
A systematic literature review was conducted to identify postpartum depression
screening practices and mental health treatment for low-income women.
Data sources and search strategy
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines were used as a basis for our methodology. PubMed and EBSCO databases
(no specified beginning date through February 2016) were comprehensively searched
using variations and combinations of the following MESH and key terms and phrases:
“pregnancy” and “pregnancy” [MESH]; “female” [MESH]; “Medicaid” [MESH]; “pov-
erty” [MESH]; “medical assistance” [MESH]; “depression, postpartum” [MESH];
“depression” and “depression” [MESH]; “depressive disorder” [MESH]; “health services
accessibility” [MESH]; “mental health services” [MESH]; “diagnosis” [MESH]; “screen-
ing”; “maternal depression and poverty”; “postpartum depression and poverty”; “mater-
nal depression in low-income women”; “maternal depression”; and/or “postpartum
depression in poor women”.
Inclusion and exclusion criteria
The inclusion and exclusion criteria for this systematic literature review were struc-
tured with the intent of understanding the heretofore-not-compiled topic of barriers to
treatment specific to low-income women with a positive postpartum depression screen.
Only empirical, English-language, peer-reviewed publications were considered for this
study. In order to focus on scholarly evidence, we excluded reviews (including
analyses), case reports, letters to the editor, executive summaries, governmental reports,
and commentaries. We also excluded articles that did not include treatment as an out-
come, articles that did not look at low-income women specifically, incomplete studies,
articles that did not have a postpartum women group, and those for which treatment
as an outcome was theoretical rather than measured. The term low-income used in this
systematic literature review is not based on one specific definition; articles that self-
identified low-income populations were considered for inclusion. Included studies
identified low-income women with the following measures: WIC recipients, women
below the federal poverty rate, income categories with low-income specifications, Early
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Head Start participants, Medicaid (and state-specific Medicaid program) recipi-
ents, women on public assistance, women who used public aid clinics, and food
stamp recipients.
Data extraction
To review data, an extraction form was designed by the researchers based on the
outcomes of the study. This included author(s), sample size, study design, study
location by country, participant demographic information, tool used to determine PPD,
how treatment was assessed, and presence of a comparison group. Disputes on article
categorization during the article evaluation process between two raters were minimized
through the employment of the extraction form.
Results
Evaluation of studies
Our initial search identified 100 articles (see Fig. 1). The titles and abstracts of these ar-
ticles (or full articles when an abstract was not available) were independently reviewed
by two authors. Any disagreements were resolved through a consensus-building joint
review of the abstract or complete article. There were no duplicate articles. We also
went through the reference lists of included studies and found two new articles for
inclusion in this review. After review, 27 articles were included in the literature review.
Additionally, 54 papers were excluded because the outcome was not related to treat-
ment, four papers were excluded because they were reviews, two papers were excluded
Fig. 1 PRISMA diagram of eligibility requirements
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because they were commentaries, five papers were excluded because low-income
women were not studied, five papers were excluded because the outcome of treatment
was theoretical, three papers were excluded because the sample was not postpartum
women, and one paper was excluded because the study had not yet been completed.
After screening the 27 articles included in the literature review, eight were excluded
based on predetermined criteria. Of those, three papers were excluded because there
was no low-income group, one paper was excluded because the outcomes were not
separated for the low-income group, two papers were excluded because the sample did
not have PPD, two were excluded because the sample was not postpartum women, and
one was excluded because the outcome of treatment was theoretical.
Analysis
Study population characteristics of 18 included studies
Using the qualitative analysis technique of constant comparative analysis, data extracted
from included articles were inductively coded by treatment characteristics and barriers.
Patterns and themes that were developed from the coded data centered on two major
topics: characteristics of PPD treatment and barriers to mental health treatment, which
have been outlined through subheadings below. Table 1 outlines the characteristics of
each article. Studies varied greatly by study design, assessment tool to determine PPD,
and treatment type. Four studies were randomized controlled studies and thus provided
the highest level of evidence. Six different standardized screen tools, three different
diagnostic codes, self-report, or a primary care evaluation were all methods used to
indicate a positive PPD screen. Some studies provided treatment for participants, and
others asked if treatment was sought.
Characteristics of postpartum depression treatment
Multiple studies found that the use of a home visitor was an effective method of
providing some level of PPD care for mothers. Beeber et al. [15] and Surkan et al. [24]
used home visitors to either identify or provide care for PPD. Both were randomized
controlled studies in which the intervention group with the home visitor showed
lower depression scores at follow-up than the control group. The subjects in
Letourneau et al. [25] agreed that in-home support would be a preferred treatment
method for PPD.
Another theme associated with positive PPD treatment was previous mental health
treatment. McGarry et al. [26] and Chaundron et al. [27] found that women who had
previously sought mental health treatment were more likely to seek treatment for PPD.
Providers and mothers were both better able to recognize symptoms of depression in
this population. Abrams et al. [28] and Logsdon et al. [29] found that religion provided
comfort for some women through practices like prayer and attending church.
Other topics associated with mothers who sought PPD treatment appeared only in
single articles. Broom et al. [30] showed that supportive text messaging, combined with
cognitive behavioral therapy, was a way to bridge access barriers in a low-income
population. Price and Proctor [31] found that the addition of postpartum screening and
treatment in community-based programs such as Healthy Start broadened access for
underserved women. While not focusing solely on PPD, Crockett et al. [32] found that
targeting social adjustment and role transition for new mothers improved PPD scores.
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Song et al. [33] found that older women sought treatment more often, due to maturity
and a greater awareness about how to find care. Finally, Surkan et al. [24] found a
potential link between self-efficacy measures (improved diet, physical activity, and
social support) and reduction in PPD symptoms.
Barriers to mental health treatment
Cultural barriers to screening and treatment were a major theme across the literature.
Stigma, racial barriers, perceptions of motherhood, language barriers, immigration
status, religion, and cultural sensitivity were all sub-themes pulled from this broader
theme. Mothers in many studies (Abrams et al. [28], Beeber et al. [15], Bobo et al. [34],
Broom et al. [30], Callister et al. [35], Letourneau et al. [25], and Geier et al. [36]) did
not seek PPD care because of the stigma attached to it. Some reported not wanting to
be seen as “crazy” or to have a “real” mental illness. Other women described withdraw-
ing during PPD because they were afraid of the stigma.
One study (Bobo et al. [34]) found that stigma may impact insurance coverage for
therapeutic treatments for PPD because of perceptions that PPD is difficult to manage.
Along the lines of stigma, perceptions of motherhood affected self-seeking patterns of
PPD treatment. Mothers in Abrams et al. [28], Callister et al. [35], and Letourneau
et al. [25] had certain ideas about mothers and motherhood. They felt that “good
mothers” do not get depressed or that feelings of sadness after having a baby were just
part of the motherhood process. Afraid of being seen as a bad mother and having the
child(ren) taken from them, many mothers ignored the feelings of PPD. In Logsdon
et al. [29], Letourneau et al. [25], and Callister et al. [35], participants attributed PPD
feelings to other causes rather than acknowledging PPD.
Similarly, Callister et al. [35] and O’Mahoney et al. [37, 38] examined immigrant and
refugee populations and found unique barriers to care, such as an undocumented
status, within that subset of low-income women. Geier et al. [36], Kozhimannil et al.
[39], and Song et al. [33] discussed racial barriers in PPD care. Overall, white women
were more likely than black or Latina women to get a diagnosis of PPD or to get treat-
ment for PPD. Within the Latina population, language barriers may pose a significant
barrier to PPD care. Language barriers on the part of the provider and mother that lead
to a lack of access for PPD care were identified by Callister et al. [35], Chaundron et al.
[27], and O’Mahoney et al. [37, 38]. Abrams et al. [28] and Song et al. [33] found that
low-income women, especially minority women, experienced an additional barrier
caused by a lack of provider cultural sensitivity. Abrams et al. [28] found that although
religion was a comfort to some women, others found it to be a barrier when beliefs
encouraged women to accept the way they feel during PPD rather than seek treatment.
Physical barriers to PPD treatment included lack of child care, lack of transportation,
lack of financial resources, and housing issues. Abrams et al. [28], Bobo et al. [34], and
Callister et al. [35] identified lack of child care to be a barrier to PPD treatment.
Abrams et al. [28], Beeber et al. [15], Bobo et al. [34], Callister et al. [35], and Crockett
et al. [32] identified lack of transportation as a major barrier to PPD treatment outside
the house. Beeber et al. [15] found that even with the convenience of a home visitor,
when women did not have a car, they would still miss appointments if a vehicle became
suddenly available to them in order to take care of other needs. Women in Crockett
et al. [32] specifically discussed a lack of public transportation in rural communities as
a barrier to care. Abrams et al. [28], Beeber et al. [15], Callister et al. [35], O’Mahoney
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et al. [37, 38], and Bobo et al. [34] found financial barriers to be one of the most signifi-
cant obstacles to PPD treatment. Abrams et al. [28] found that women were not sure if
insurance covered mental health treatment so they did not risk the potential expend-
iture. Women in Callister et al. [35] noted, “if she has no money, how is she going to
find help [with PPD]?” and “as Hispanics we do not have insurance and money is what
really counts.” Immigrant or refugee women in O’Mahoney et al. [37, 38] were
economically dependent on their sponsors, so some of these women were not allowed
to get treatment. Finally, Beeber et al. [15] identified housing barriers to PPD treatment.
The home visitor found it difficult to focus solely on PPD symptoms when extenuating
circumstances, like poor housing, existed.
Different barriers within the health care structure were also discussed and included:
insurance issues, access to care, medication concerns, lack of awareness by the mother
about PPD itself or treatment options, previous negative experiences with the medical
system, and provider error. Bobo et al. [34] and Geier et al. [36] spoke of insurance bar-
riers to PPD treatment. Those without insurance or with inconsistent insurance found
it much more difficult, or impossible, to access PPD care. Abrams et al. [28], Broom
et al. [30], Letourneau et al. [25], Price and Proctor [31], and O’Mahoney et al. [37, 38]
found additional barriers regarding access to PPD treatment. Women did not know
where to find treatment, how to get engaged in treatment, or were geographically
removed from treatment. O’Mahoney et al. [37, 38] and Song et al. [33] found that
women were not aware of PPD in general or the existence of treatment options. Geier
et al. [36] found concerns about the safety of antidepressant use while breastfeeding,
which was addressed as a barrier to care. Providers were perceived as the cause of two
barriers: negative prior experiences by women with PPD and provider error. Abrams
et al. [28], Letorneau et al. [25], and O’Mahoney et al. [37, 38] found that women who
had previously tried to seek treatment for PPD had been told to wait and see what hap-
pened or were given a pharmaceutical intervention without much discussion. This
made women feel minimized or dismissed by medical professionals and impacted
subsequent treatment for PPD.
O’Mahoney et al. [37, 38] found that women who had had previous health care
encounters experienced an unequal balance of power between the provider and patient,
which impacted the decision to use the health care system. Geier et al. [36], Chaundron
et al. [27], and Letourneau et al. [25] found provider error to be a barrier to treatment
for PPD. Geier et al. [36] found that obstetrician/gynecologists felt it to be their respon-
sibility to provide mental health services for PPD, thereby not making a referral to a
mental health provider. Chaundron et al. [27] and Letourneau et al. [25] found that
providers screened women too early or were not effective in verbally evaluating women
because of differences in viewpoints about what constitutes PPD. O’Mahoney et al.
[37, 38] found that women also felt that providers were downplaying the symptoms
they were experiencing.
Social barriers were the final theme extracted regarding barriers to treatment, with
sub-themes of social support, self-help/self-reliance, and policy issues. Abrams et al.
[28], Callister et al. [35], Letourneau et al. [25], Logsdon et al. [29], and O’Mahoney
et al. [37, 38] found social support barriers to seeking PPD treatment. Callister et al.
[35] and Letourneau et al. [25] found that women isolated themselves from others
because of PPD. Abrams et al. [28], Callister et al. [35], Logsdon et al. [29], and
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O’Mahoney et al. [37, 38] found that women often seek help from a social contact
rather than seeking professional care. Those without social relationships felt an
additional burden when dealing with PPD. Abrams et al. [28], Letourneau et al.
[25], and Price and Proctor [31] found that women were more likely to address
PPD through self-help/self-reliance than go through a professional channel. One
common method for self-help was positive self-talk. Kozhimannil et al. [40] found
no increase in PPD treatment from before a law was passed that mandated PPD
screening and after the law was passed.
Discussion
Multiple themes were discussed as possible reasons why low-income women are or are
not able to get treatment for PPD after a positive screen. The objective of this literature
review is not to address ways to surmount barriers to PPD treatment, as the barriers
vary by situation. Rather, the authors focus on answering the key question, which seeks
to determine the characteristics associated with access to mental health treatment for
low-income women with a positive postpartum depression screen in Western countries.
This review provides a compilation of obstacles that low-income women face in acces-
sing treatment for PPD; however, general recommendations are offered in the conclu-
sion. This is also not a critique on screening methods and/or the efficacy of treatment
type. The authors do consider certain patterns based on study design choices, like
screening tool and treatment type.
Considering the targeted population for this review and the fact that minority popula-
tions are more likely to be poor and uninsured [41], it was not surprising that financial
barriers were a main reason that women did not seek treatment for PPD. Financial
barriers were broader than not merely being able to pay for treatment; women with
children could not afford to pay someone to watch the child(ren) during treatment,
could not afford transportation to go for treatment, or had insurance issues that
impeded getting treatment. Even if a low-income woman had a positive screen for PPD,
either through self-recognition of symptoms or a screening tool administered by a
clinician, overcoming the next set of barriers was often too difficult. Studies in which a
treatment group included home visitors that provided some level of mental health
services showed that depression scores were lower for the women with in-home care.
Financial barriers may be addressed through home visiting programs because the trans-
portation factor is eliminated. The two studies [15, 24] that showed success through
the employment of home visitors as part of the treatment group were randomized
controlled studies, providing strong evidence for home visitors as a method of
overcoming some barriers low-income women with PPD face.
Stigma was a major barrier to treatment for this population. Low-income women
may already feel stigmatized for socioeconomic reasons, and the fear of that stigma
being exacerbated by a mental illness may make seeking treatment not seem worth-
while. In addition to reducing financial costs of treatment, home visitation treatment of
PPD also increases the opportunity for in-home providers to foster positive social
support for the mother among her immediate and extended social circle through
education about PPD and addressing misperceptions related to treatment. This includes
educating both the mother and members of her support system about the symptoms of
PPD, emphasizing that they are not alone in experiencing these symptoms, and
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explaining that seeking treatment is not a sign of weakness or reflection of a mother’s
parenting ability. A woman may also feel freer to talk about her feelings in her home
without the fear of being stigmatized.
Many articles reviewed showed that women were not familiar with PPD, did not
know how to get treatment for PPD, or thought that PPD was a normal part of mother-
hood. However, some of these articles did not use standardized methods of assessing
PPD, which may minimize the level of evidence for this theme. Cultural perceptions
about how a mother should feel and act were major barriers to recognizing that PPD
symptoms were an issue. Many women felt that even if they were screened for PPD by
a clinician, the issue was not explained in a way that they understood. Many women
thought that they could overcome PPD symptoms themselves. These themes surround-
ing a lack of awareness about PPD and its treatment make it clear that education for
providers and patients is vital to normalizing PPD and treatment.
Many women did not want to get treatment for PPD due to negative experiences
with mental health or other medical services in the past. Low-income women felt that
they were talked down to or dismissed by medical providers; however, previous mental
health treatment was seen to be positively associated with treatment for PPD. This is
perhaps due to an increased awareness about symptoms. Along the same lines, the
literature suggests that physicians must also be aware of the cultural and language
differences and barriers that affect low-income women seeking treatment and how
these play a role in their health-seeking behavior. This extends beyond using cultural
competence as a tool or skill that can be taught and mastered to assist low-income
women; rather, there should be a continuous effort by the provider to develop cultural
knowledge to provide culturally appropriate treatment. Although none of the included
articles for this study directly addressed the confounding role that racial discrimin-
ation could play in the differences of treatment for low-income women, specifically
women of color, it is important to acknowledge. Kozhimannil et al. [39] found that
of the reviewed Medicaid population, white postpartum women were significantly
more likely to have an International Classification of Diseases, Ninth Revision
(ICD-9) code for an outpatient mental health visit or national drug code for anti-
depressants (i.e., significantly more likely to obtain PPD treatment) than black or
Latina women. This indicates that there may be an opportunity to explore this
theme in future studies.
When looking at the paper by Kozhimannil et al. [40], in which a mandate for PPD
screening did not improve treatment initiation, follow-up, or continued care, the
authors suggested that perhaps lawmakers did not consider or address barriers to care
in the development of this policy. Studies that looked at specific interventions that
focused on some type of community-level support or self-care practices showed
improvements in PPD scores. A policy intervention such as that described in the paper
by Kozhimannil et al. [40] that only mandates clinicians to complete a checklist that
includes a basic PPD screen during postpartum clinical visits may be enhanced when
combined with interventions that work to boost the mother’s mental well-being
and that also address overcoming barriers to care. In creating strategies to im-
prove access to PPD treatment among low-income women, policymakers need to
issue additional guidance on how to best operationalize these policies in ethnic-
ally and racially diverse and underserved populations. Creating the policy alone
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without intentional focus on how it will be implemented is no benefit to those
experiencing symptoms of PPD, especially those who are already underserved.
Limitations
One limitation of this literature review was the publication bias that resulted from the
limited number of studies that met the inclusion criteria. Another limitation was the
generalizablility of the results or conclusions, as all articles that met the inclusion
criteria for this review were conducted in Western countries. Because studies on PPD
outside of Western countries did not necessarily look at the same sample population as
this review, it is not possible to determine if the low-income definition used for this
paper is generalizable to developing countries. It also must be noted that barriers to
treatment are not the only indicator of PPD outcomes or symptoms and that not all
PPD assessment tools and/or treatments are standardized or equally efficacious.
Conclusions
Addressing the perceived barriers to mental health treatment for low-income women
with PPD symptoms is crucial to increasing access to treatment and receipt of care in
this population. Based on the literature examined, there is a need for providers to
recognize that formal treatment must take into account the unique cultural experiences
of this population and should adjust accordingly to fit the patient’s needs. This may
require innovative approaches that move beyond the clinical setting to community-
level interventions in order to help dispel negative perceptions regarding PPD and
support normalization of the condition. The identification of PPD by a health care
worker should be done in a way that engages the patient and ensures that she under-
stands the condition and treatment options. A practitioner should also complete PPD
assessment of some type at all prenatal and postpartum visits in order to assess
response trends and catch changes in depressive symptoms. More research is needed to
understand ways of overcoming the barriers identified in this review. There is also the
need for more studies of high evidence level to be completed on the specific population
of low-income women with a positive PPD screen.
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